Literature DB >> 12832386

Increased risk of early menopausal transition and natural menopause after poor response at first IVF treatment.

Evelien J de Boer1, Isolde den Tonkelaar, Egbert R te Velde, Curt W Burger, Flora E van Leeuwen.   

Abstract

BACKGROUND: Our aim was to examine whether women who had a low number of retrieved oocytes at their first IVF attempt reach the menopausal transition and/or the natural menopause earlier than women of similar ages with a high number of retrieved oocytes.
METHODS: We conducted a retrospective cohort study among women in The Netherlands who received IVF treatment between 1983 and 1995. For the present study, we selected all cohort members who had a regular menstrual cycle at the time of the first visit to the gynaecologist (n = 4601). After a median follow-up of 5.5 years, 3871 (84%) women still had a regular menstrual cycle pattern, 547 (12%) women had entered the menopausal transition (i.e. no menses for 3-11 months, use of HRT or irregular menstrual cycles) and 27 (1%) women had reached natural menopause. We examined whether the quantity and the quality of the retrieved oocytes were related to an early menopausal transition and early menopause. The live birth rate per embryo transfer was used as indicative of the quality of the oocytes.
RESULTS: The age-adjusted odds ratio (OR) for having entered the menopausal transition/natural menopause for women with a poor response (0-3 oocytes) at their first IVF attempt was 3.1 [95% confidence interval (CI) 2.4-3.8] compared with women with a normal response (>3 oocytes). Women who were stimulated with gonadotrophins during IVF treatment but did not undergo an IVF puncture because of an anticipated poor response (cancelled IVF cycle) had an age-adjusted OR of 3.2 (95% CI 2.3-4.3). There was no significant difference in the odds of reaching the menopausal transition/natural menopause, after adjustment for age and the number or retrieved oocytes, between women who did and did not have a live birth following their first embryo transfer (OR = 1.3; 95% CI 0.95-1.7).
CONCLUSIONS: These results indicate that a low remaining quantity of oocytes, as reflected by a low number of retrieved oocytes at first IVF treatment, is an important predictor of the risk of an early menopausal transition/natural menopause. The quality of the oocytes did not affect the risk of an early menopausal transition/natural menopause once the number of retrieved oocytes had been taken into account. Our findings support the concept that the number of remaining follicles in the ovaries is one of the main aspects of reproductive ageing.

Entities:  

Mesh:

Year:  2003        PMID: 12832386     DOI: 10.1093/humrep/deg278

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  16 in total

1.  Enhanced hypothalamic-pituitary sensitivity to estrogen in premenopausal women with diminished ovarian reserve compared with older perimenopausal controls.

Authors:  Katie Zhang; Gohar Zeitlian; Goli Adel; Nanette F Santoro; Lubna Pal
Journal:  Menopause       Date:  2011-08       Impact factor: 2.953

2.  Correlation of telomere length and telomerase activity with occult ovarian insufficiency.

Authors:  Samantha Butts; Harold Riethman; Sarah Ratcliffe; Alka Shaunik; Christos Coutifaris; Kurt Barnhart
Journal:  J Clin Endocrinol Metab       Date:  2009-10-28       Impact factor: 5.958

3.  Simple tools for assessment of ovarian reserve (OR): individual ovarian dimensions are reliable predictors of OR.

Authors:  Stacea Bowen; John Norian; Nanette Santoro; Lubna Pal
Journal:  Fertil Steril       Date:  2007-04-06       Impact factor: 7.329

4.  Blood cell mitochondrial DNA content and premature ovarian aging.

Authors:  Marco Bonomi; Edgardo Somigliana; Chiara Cacciatore; Marta Busnelli; Raffaella Rossetti; Silvia Bonetti; Alessio Paffoni; Daniela Mari; Guido Ragni; Luca Persani
Journal:  PLoS One       Date:  2012-08-03       Impact factor: 3.240

5.  Contemporary genetic technologies and female reproduction.

Authors:  B C J M Fauser; K Diedrich; P Bouchard; F Domínguez; M Matzuk; S Franks; S Hamamah; C Simón; P Devroey; D Ezcurra; C M Howles
Journal:  Hum Reprod Update       Date:  2011-09-06       Impact factor: 15.610

6.  Using web-based and paper-based questionnaires for collecting data on fertility issues among female childhood cancer survivors: differences in response characteristics.

Authors:  Marleen H van den Berg; Annelies Overbeek; Helena J van der Pal; A Birgitta Versluys; Dorine Bresters; Flora E van Leeuwen; Cornelis B Lambalk; Gertjan J L Kaspers; Eline van Dulmen-den Broeder
Journal:  J Med Internet Res       Date:  2011-09-29       Impact factor: 5.428

7.  Risk of borderline and invasive ovarian tumours after ovarian stimulation for in vitro fertilization in a large Dutch cohort.

Authors:  F E van Leeuwen; H Klip; T M Mooij; A M G van de Swaluw; C B Lambalk; M Kortman; J S E Laven; C A M Jansen; F M Helmerhorst; B J Cohlen; W N P Willemsen; J M J Smeenk; A H M Simons; F van der Veen; J L H Evers; P A van Dop; N S Macklon; C W Burger
Journal:  Hum Reprod       Date:  2011-10-26       Impact factor: 6.918

Review 8.  Biological versus chronological ovarian age: implications for assisted reproductive technology.

Authors:  Carlo Alviggi; Peter Humaidan; Colin M Howles; Donald Tredway; Stephen G Hillier
Journal:  Reprod Biol Endocrinol       Date:  2009-09-22       Impact factor: 5.211

9.  The OPTIMIST study: optimisation of cost effectiveness through individualised FSH stimulation dosages for IVF treatment. A randomised controlled trial.

Authors:  Theodora C van Tilborg; Marinus J C Eijkemans; Joop S E Laven; Carolien A M Koks; Jan Peter de Bruin; Gabrielle J Scheffer; Ron J T van Golde; Kathrin Fleischer; Annemieke Hoek; Annemiek W Nap; Walter K H Kuchenbecker; Petra A Manger; Egbert A Brinkhuis; Arne M van Heusden; Alexander V Sluijmer; Arie Verhoeff; Marcel H A van Hooff; Jaap Friederich; Jesper M J Smeenk; Janet Kwee; Harold R Verhoeve; Cornelis B Lambalk; Frans M Helmerhorst; Fulco van der Veen; Ben Willem J Mol; Helen L Torrance; Frank J M Broekmans
Journal:  BMC Womens Health       Date:  2012-09-18       Impact factor: 2.809

10.  A nationwide study on reproductive function, ovarian reserve, and risk of premature menopause in female survivors of childhood cancer: design and methodological challenges.

Authors:  Annelies Overbeek; Marleen H van den Berg; Leontien C M Kremer; Marry M van den Heuvel-Eibrink; Wim J E Tissing; Jacqueline J Loonen; Birgitta Versluys; Dorine Bresters; Gertjan J L Kaspers; Cornelis B Lambalk; Flora E van Leeuwen; Eline van Dulmen-den Broeder
Journal:  BMC Cancer       Date:  2012-08-23       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.